In those patients diagnosed with IDH2m AML that was not co-mutated with either NPM1 and/or FLT3-ITD, persistent detection of IDH2m pre-transplant was common and associated with increased relapse and death after transplant. This evidence concerns the gene NPM1 and acute myeloid leukemia.